Pure Global

IL-6 - India CDSCO Medical Device Registration

IL-6 is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2021/000365_ed2162ba3c2a21b6a439202c3e08b2e4_371dae65e1b7f1018eeb8f4d2a84fa03. This device is marketed under the brand name AFIAS Infliximab . The license holder is BODITECH MED INDIA PRIVATE LIMITED, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
IL-6
UID: IMP/IVD/2021/000365_ed2162ba3c2a21b6a439202c3e08b2e4_371dae65e1b7f1018eeb8f4d2a84fa03

Brand Name

AFIAS Infliximab

Device Class

Class B

Approving Authority

CDSCO

Product Information

AFIAS IL-6 is a fluorescence Immunoassay (AFIAS Infliximab ) for the quantitative detection of interleukin-6 (AFIAS Infliximab ) in human whole blood/serum/plasma. It is useful as an aid in management and monitoring of inflammatory disease. For in vitro diagnostic use only

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing